Riskpilot← Back to searchSign inGet full accessThe Bleeding Edge AB
ABActiveOrg 5568416266Buavägen 16Activities of advertising agencies · NACE 7311Est. 20111 employees
Revenue 2024
SEK 134K
EBITDA margin
44.0%
Equity ratio
81.4%
Financial strength
Net profit 2024
SEK 47K
1 employees
| Revenue | SEK 134K | — |
| EBITDA | SEK 59K | — |
| Net profit | SEK 47K | — |
| Total assets | SEK 145K | +101% |
| Equity | SEK 118K | +64% |
| Employees | 1 | — |
Legal name
The Bleeding Edge AB
Org number
5568416266
Legal form
Aktiebolag
NACE code
7311 · Activities of advertising agencies
Founded
10 februari 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget ska bedriva konsultverksamhet och rådgivning inom innovation, AI, kreativt idéskapande, design, marknadsföring, försäljning, konceptutveckling och investeringar.
Address
Buavägen 16
Email
davidwedebrant@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 134 |
| Staff expenses | — | — | — | — | — |
| EBITDA | — | — | — | — | 59 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | 0 | 0 | 59 |
| Net financials | — | — | — | — | — |
| Profit before tax | 0 | 0 | 0 | 0 | 59 |
| Tax | −0 | −0 | −0 | −0 | −12 |
| Net profit | 0 | 0 | 0 | 0 | 47 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 72 | 72 | 72 | 72 | 145 |
| Equity | 72 | 72 | 72 | 72 | 118 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 26 |
| Total debt | — | — | — | — | 26 |
EBITDA margin
44.0%
This company
15.8%
Market median
+178% vs market
20202024
Equity ratio
81.4%
This company
38.2%
Market median
+113% vs market
20202024
Return on equity
39.8%
This company
18.4%
Market median
+116% vs market
20202024
Net profit margin
35.1%
This company
8.1%
Market median
+333% vs market
20202024
Asset turnover
0.92×
This company
1.12×
Market median
+18% vs market
20202024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of The Bleeding Edge AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Carl-Gustav Wedebrant | Chief Executive Officer | 0 companies |
| Jarl Peter Wedebrant | Deputy Board Member | 0 companies |